BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Harrison PJ, Cipriani A, Harmer CJ, Nobre AC, Saunders K, Goodwin GM, Geddes JR. Innovative approaches to bipolar disorder and its treatment. Ann N Y Acad Sci 2016;1366:76-89. [PMID: 27111134 DOI: 10.1111/nyas.13048] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Fristad MA. Editorial: Mood Instability: What It Is, Why It Matters, and What to Do About It. J Am Acad Child Adolesc Psychiatry 2022:S0890-8567(22)00121-6. [PMID: 35346786 DOI: 10.1016/j.jaac.2022.03.012] [Reference Citation Analysis]
2 Bassett D, Boyce P, Lyndon B, Mulder R, Parker G, Porter R, Singh A, Bell E, Hamilton A, Morris G, Malhi GS. Guidelines for the management of psychosis in the context of mood disorders. Schizophrenia Research 2022;241:187-96. [DOI: 10.1016/j.schres.2022.01.047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Saccaro LF, Amatori G, Cappelli A, Mazziotti R, Dell'Osso L, Rutigliano G. Portable technologies for digital phenotyping of bipolar disorder: A systematic review. J Affect Disord 2021;295:323-38. [PMID: 34488086 DOI: 10.1016/j.jad.2021.08.052] [Reference Citation Analysis]
4 Hong JSW, Atkinson LZ, Al-Juffali N, Awad A, Geddes JR, Tunbridge EM, Harrison PJ, Cipriani A. Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale. Mol Psychiatry 2021. [PMID: 34819636 DOI: 10.1038/s41380-021-01386-6] [Reference Citation Analysis]
5 Shinozaki M, Yasui-Furukori N, Adachi N, Ueda H, Hongo S, Azekawa T, Kubota Y, Katsumoto E, Edagawa K, Goto E, Miki K, Kato M, Nakagawa A, Kikuchi T, Tsuboi T, Watanabe K, Shimoda K, Yoshimura R. Differences in prescription patterns between real-world outpatients with bipolar I and II disorders in the MUSUBI survey. Asian J Psychiatr 2021;67:102935. [PMID: 34844178 DOI: 10.1016/j.ajp.2021.102935] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Besag FMC, Vasey MJ, Sharma AN, Lam ICH. Efficacy and safety of lamotrigine in the treatment of bipolar disorder across the lifespan: a systematic review. Ther Adv Psychopharmacol 2021;11:20451253211045870. [PMID: 34646439 DOI: 10.1177/20451253211045870] [Reference Citation Analysis]
7 Simon J, Pari AAA, Wolstenholme J, Berger M, Goodwin GM, Geddes JR. The costs of bipolar disorder in the United Kingdom. Brain Behav 2021;11:e2351. [PMID: 34523820 DOI: 10.1002/brb3.2351] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Yerushalmi M, Sixsmith A, Pollock Star A, King DB, O'Rourke N. Ecological Momentary Assessment of Bipolar Disorder Symptoms and Partner Affect: Longitudinal Pilot Study. JMIR Form Res 2021;5:e30472. [PMID: 34473069 DOI: 10.2196/30472] [Reference Citation Analysis]
9 Liu Y, Tong Y, Huang L, Chen J, Yan S, Yang F. Factors related to retinal nerve fiber layer thickness in bipolar disorder patients and major depression patients. BMC Psychiatry 2021;21:301. [PMID: 34112131 DOI: 10.1186/s12888-021-03270-7] [Reference Citation Analysis]
10 Faurholt-Jepsen M, Lindbjerg Tønning M, Fros M, Martiny K, Tuxen N, Rosenberg N, Busk J, Winther O, Thaysen-Petersen D, Aamund KA, Tolderlund L, Bardram JE, Kessing LV. Reducing the rate of psychiatric re-admissions in bipolar disorder using smartphones-The RADMIS trial. Acta Psychiatr Scand 2021;143:453-65. [PMID: 33354769 DOI: 10.1111/acps.13274] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
11 Santos R, Linker SB, Stern S, Mendes APD, Shokhirev MN, Erikson G, Randolph-Moore L, Racha V, Kim Y, Kelsoe JR, Bang AG, Alda M, Marchetto MC, Gage FH. Deficient LEF1 expression is associated with lithium resistance and hyperexcitability in neurons derived from bipolar disorder patients. Mol Psychiatry 2021. [PMID: 33398088 DOI: 10.1038/s41380-020-00981-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 17.0] [Reference Citation Analysis]
12 Ossola P, Garrett N, Sharot T, Marchesi C. Belief updating in bipolar disorder predicts time of recurrence. Elife 2020;9:e58891. [PMID: 33168133 DOI: 10.7554/eLife.58891] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Orsolini L, Fiorani M, Volpe U. Digital Phenotyping in Bipolar Disorder: Which Integration with Clinical Endophenotypes and Biomarkers? Int J Mol Sci 2020;21:E7684. [PMID: 33081393 DOI: 10.3390/ijms21207684] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Quested DJ, Gibson JC, Sharpley AL, Cordey JH, Economou A, De Crescenzo F, Voysey M, Lawson J, Rendell JM, Al-Taiar H, Lennox A, Ahmad F, Geddes JR. Melatonin In Acute Mania Investigation (MIAMI-UK). A randomized controlled trial of add-on melatonin in bipolar disorder. Bipolar Disord 2021;23:176-85. [PMID: 32474993 DOI: 10.1111/bdi.12944] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Di Martino RMC, Bottegoni G, Seghetti F, Russo D, Penna I, De Simone A, Ottonello G, Mandrup Bertozzi S, Armirotti A, Bandiera T, Belluti F, Cavalli A. Multitarget Compounds for Bipolar Disorder: From Rational Design to Preliminary Pharmacokinetic Evaluation. ChemMedChem 2020;15:949-54. [PMID: 32267999 DOI: 10.1002/cmdc.202000210] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
16 S Valvassori S, H Cararo J, Peper-Nascimento J, L Ferreira C, F Gava F, C Dal-Pont G, L Andersen M, Quevedo J. Protein kinase C isoforms as a target for manic-like behaviors and oxidative stress in a dopaminergic animal model of mania. Prog Neuropsychopharmacol Biol Psychiatry 2020;101:109940. [PMID: 32243997 DOI: 10.1016/j.pnpbp.2020.109940] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Shaw RJ, Mackay D, Pell JP, Padmanabhan S, Bailey DS, Smith DJ. The relationship between antihypertensive medications and mood disorders: analysis of linked healthcare data for 1.8 million patients. Psychol Med 2021;51:1183-91. [PMID: 31973782 DOI: 10.1017/S0033291719004094] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
18 Bauer M, Glenn T, Geddes J, Gitlin M, Grof P, Kessing LV, Monteith S, Faurholt-Jepsen M, Severus E, Whybrow PC. Smartphones in mental health: a critical review of background issues, current status and future concerns. Int J Bipolar Disord. 2020;8:2. [PMID: 31919635 DOI: 10.1186/s40345-019-0164-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 12.0] [Reference Citation Analysis]
19 Phillips AL, Burr RL, Dunner DL. Repetitive Transcranial Magnetic Stimulation in the Treatment of Bipolar Depression: Experience From a Clinical Setting. Journal of Psychiatric Practice 2020;26:37-45. [DOI: 10.1097/pra.0000000000000447] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
20 Czarny P, Bialek K, Ziolkowska S, Strycharz J, Sliwinski T. DNA damage and repair in neuropsychiatric disorders. What do we know and what are the future perspectives? Mutagenesis 2019. [DOI: 10.1093/mutage/gez035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
21 Jochim J, Rifkin-Zybutz RP, Geddes J, Cipriani A. Valproate for acute mania. Cochrane Database Syst Rev 2019;10:CD004052. [PMID: 31621892 DOI: 10.1002/14651858.CD004052.pub2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
22 McDermott BE, Warburton K, Auletta-Young C. A longitudinal description of incompetent to stand trial admissions to a state hospital. CNS Spectr 2020;25:223-36. [PMID: 31576796 DOI: 10.1017/S1092852919001342] [Reference Citation Analysis]
23 Hossain S, Mainali P, Bhimanadham NN, Imran S, Ahmad N, Patel RS. Medical and Psychiatric Comorbidities in Bipolar Disorder: Insights from National Inpatient Population-based Study. Cureus 2019;11:e5636. [PMID: 31700739 DOI: 10.7759/cureus.5636] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
24 Faurholt-Jepsen M, Geddes JR, Goodwin GM, Bauer M, Duffy A, Vedel Kessing L, Saunders K. Reporting guidelines on remotely collected electronic mood data in mood disorder (eMOOD)-recommendations. Transl Psychiatry 2019;9:162. [PMID: 31175283 DOI: 10.1038/s41398-019-0484-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
25 Faurholt‐jepsen M, Frost M, Busk J, Christensen EM, Bardram JE, Vinberg M, Kessing LV. Is smartphone‐based mood instability associated with stress, quality of life, and functioning in bipolar disorder? Bipolar Disord 2019;21:611-20. [DOI: 10.1111/bdi.12796] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
26 Henshall C, Cipriani A, Ruvolo D, Macdonald O, Wolters L, Koychev I. Implementing a digital clinical decision support tool for side effects of antipsychotics: a focus group study. Evid Based Ment Health 2019;22:56-60. [PMID: 30987972 DOI: 10.1136/ebmental-2019-300086] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
27 Faurholt-Jepsen M, Frost M, Christensen EM, Bardram JE, Vinberg M, Kessing LV. The effect of smartphone-based monitoring on illness activity in bipolar disorder: the MONARCA II randomized controlled single-blinded trial. Psychol Med. 2020;50:838-848. [PMID: 30944054 DOI: 10.1017/s0033291719000710] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 15.0] [Reference Citation Analysis]
28 Egher C. Bipolar patients and creative online practices: Sharing experiences of controversial treatments. Health (London) 2019;23:458-77. [PMID: 30919655 DOI: 10.1177/1363459319838315] [Reference Citation Analysis]
29 Atkinson LZ, Colbourne L, Smith A, Harmer CH, Nobre AC, Rendell J, Jones H, Hinds C, Mould A, Tunbridge EM, Cipriani A, Geddes JR, Saunders KEA, Harrison PJ. The Oxford study of Calcium channel Antagonism, Cognition, Mood instability and Sleep (OxCaMS): study protocol for a randomised controlled, experimental medicine study. Trials 2019;20:120. [PMID: 30755265 DOI: 10.1186/s13063-019-3175-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
30 Faurholt-Jepsen M, Frost M, Busk J, Christensen EM, Bardram JE, Vinberg M, Kessing LV. Differences in mood instability in patients with bipolar disorder type I and II: a smartphone-based study. Int J Bipolar Disord 2019;7:5. [PMID: 30706154 DOI: 10.1186/s40345-019-0141-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
31 Fries GR, Walss-bass C, Bauer ME, Teixeira AL. Revisiting inflammation in bipolar disorder. Pharmacology Biochemistry and Behavior 2019;177:12-9. [DOI: 10.1016/j.pbb.2018.12.006] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 14.3] [Reference Citation Analysis]
32 Szmulewicz AG, Martino DJ, Strejilevich SA. Characterization of Mood Instability through Bipolar Disorders: A cluster-analytic approach using weekly prospective life-chart methodology. Eur Psychiatry 2019;57:52-7. [PMID: 30677548 DOI: 10.1016/j.eurpsy.2018.10.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
33 Bauer M, Andreassen OA, Geddes JR, Vedel Kessing L, Lewitzka U, Schulze TG, Vieta E. Areas of uncertainties and unmet needs in bipolar disorders: clinical and research perspectives. Lancet Psychiatry 2018;5:930-9. [PMID: 30146246 DOI: 10.1016/S2215-0366(18)30253-0] [Cited by in Crossref: 59] [Cited by in F6Publishing: 34] [Article Influence: 14.8] [Reference Citation Analysis]
34 Amerio A, Ossola P, Scagnelli F, Odone A, Allinovi M, Cavalli A, Iacopelli J, Tonna M, Marchesi C, Ghaemi S. Safety and efficacy of lithium in children and adolescents: A systematic review in bipolar illness. Eur psychiatr 2018;54:85-97. [DOI: 10.1016/j.eurpsy.2018.07.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
35 Tomlinson A, Cipriani A. The times they are a-changin’. Evid Based Mental Health 2018;21:81-81. [DOI: 10.1136/ebmental-2018-300035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
36 Zabegalov KN, Kolesnikova TO, Khatsko SL, Volgin AD, Yakovlev OA, Amstislavskaya TG, Alekseeva PA, Meshalkina DA, Friend AJ, Bao W, Demin KA, Gainetdinov RR, Kalueff AV. Understanding antidepressant discontinuation syndrome (ADS) through preclinical experimental models. European Journal of Pharmacology 2018;829:129-40. [DOI: 10.1016/j.ejphar.2018.04.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
37 Awad A, Cipriani A. Mood instability and regulatory oversight: Checkpoints on the pursuit of 'true' mood stabilisers. Aust N Z J Psychiatry 2018;52:87-8. [PMID: 28673101 DOI: 10.1177/0004867417717800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
38 Cloutier M, Greene M, Guerin A, Touya M, Wu E. The economic burden of bipolar I disorder in the United States in 2015. Journal of Affective Disorders 2018;226:45-51. [DOI: 10.1016/j.jad.2017.09.011] [Cited by in Crossref: 72] [Cited by in F6Publishing: 54] [Article Influence: 18.0] [Reference Citation Analysis]
39 Harrison PJ, Geddes JR, Tunbridge EM. The Emerging Neurobiology of Bipolar Disorder. Trends Neurosci 2018;41:18-30. [PMID: 29169634 DOI: 10.1016/j.tins.2017.10.006] [Cited by in Crossref: 85] [Cited by in F6Publishing: 65] [Article Influence: 17.0] [Reference Citation Analysis]
40 Beyer DKE, Freund N. Animal models for bipolar disorder: from bedside to the cage. Int J Bipolar Disord 2017;5:35. [PMID: 29027157 DOI: 10.1186/s40345-017-0104-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]
41 Henshall C, Marzano L, Smith K, Attenburrow MJ, Puntis S, Zlodre J, Kelly K, Broome MR, Shaw S, Barrera A, Molodynski A, Reid A, Geddes JR, Cipriani A. A web-based clinical decision tool to support treatment decision-making in psychiatry: a pilot focus group study with clinicians, patients and carers. BMC Psychiatry 2017;17:265. [PMID: 28732477 DOI: 10.1186/s12888-017-1406-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
42 Houghton KT, Forrest A, Awad A, Atkinson LZ, Stockton S, Harrison PJ, Geddes JR, Cipriani A. Biological rationale and potential clinical use of gabapentin and pregabalin in bipolar disorder, insomnia and anxiety: protocol for a systematic review and meta-analysis. BMJ Open 2017;7:e013433. [PMID: 28348186 DOI: 10.1136/bmjopen-2016-013433] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
43 Ashok AH, Marques TR, Jauhar S, Nour MM, Goodwin GM, Young AH, Howes OD. The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment. Mol Psychiatry 2017;22:666-79. [PMID: 28289283 DOI: 10.1038/mp.2017.16] [Cited by in Crossref: 217] [Cited by in F6Publishing: 174] [Article Influence: 43.4] [Reference Citation Analysis]
44 Monson ET, Pirooznia M, Parla J, Kramer M, Goes FS, Gaine ME, Gaynor SC, de Klerk K, Jancic D, Karchin R, McCombie WR, Zandi PP, Potash JB, Willour VL. Assessment of Whole-Exome Sequence Data in Attempted Suicide within a Bipolar Disorder Cohort. Mol Neuropsychiatry 2017;3:1-11. [PMID: 28879196 DOI: 10.1159/000454773] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
45 Kiełczykowska M, Musik I, Kurzepa J, Żelazowska R, Lewandowska A, Paździor M, Kocot J. The Influence of Lithium and/or Selenium Treatment on Homeostasis of Chosen Bioelements in Rats. Biol Trace Elem Res 2017;178:79-85. [PMID: 27957665 DOI: 10.1007/s12011-016-0906-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
46 Ortiz A, Grof P. Electronic monitoring of self-reported mood: the return of the subjective? Int J Bipolar Disord 2016;4:28. [PMID: 27900735 DOI: 10.1186/s40345-016-0069-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
47 Malhi GS, Byrow Y, Outhred T, Fritz K. Exclusion of overlapping symptoms in DSM-5 mixed features specifier: heuristic diagnostic and treatment implications. CNS Spectr 2017;22:126-33. [DOI: 10.1017/s1092852916000614] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
48 Kim Y, Zhang Y, Pang K, Kang H, Park H, Lee Y, Lee B, Lee HJ, Kim WK, Geum D, Han K. Bipolar Disorder Associated microRNA, miR-1908-5p, Regulates the Expression of Genes Functioning in Neuronal Glutamatergic Synapses. Exp Neurobiol 2016;25:296-306. [PMID: 28035180 DOI: 10.5607/en.2016.25.6.296] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
49 Kiełczykowska M, Musik I, Żelazowska R, Lewandowska A, Kurzepa J, Kocot J. Homeostasis of chosen bioelements in organs of rats receiving lithium and/or selenium. Biometals 2016;29:873-9. [PMID: 27476158 DOI: 10.1007/s10534-016-9958-9] [Reference Citation Analysis]
50 Cipriani A, Saunders K, Attenburrow MJ, Stefaniak J, Panchal P, Stockton S, Lane TA, Tunbridge EM, Geddes JR, Harrison PJ. A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development. Mol Psychiatry 2016;21:1324-32. [PMID: 27240535 DOI: 10.1038/mp.2016.86] [Cited by in Crossref: 68] [Cited by in F6Publishing: 60] [Article Influence: 11.3] [Reference Citation Analysis]